Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch & Lomb (BLCO) Asset Writedowns and Impairment (2021 - 2024)

Historic Asset Writedowns and Impairment for Bausch & Lomb (BLCO) over the last 3 years, with Q2 2024 value amounting to $5.0 million.

  • Bausch & Lomb's Asset Writedowns and Impairment changed N/A to $5.0 million in Q2 2024 from the same period last year, while for Jun 2025 it was $5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.0 million for FY2024, which is N/A changed from last year.
  • Per Bausch & Lomb's latest filing, its Asset Writedowns and Impairment stood at $5.0 million for Q2 2024.
  • Over the past 5 years, Bausch & Lomb's Asset Writedowns and Impairment peaked at $8.0 million during Q3 2021, and registered a low of $1.0 million during Q1 2021.
  • In the last 3 years, Bausch & Lomb's Asset Writedowns and Impairment had a median value of $1.5 million in 2021 and averaged $3.0 million.
  • Over the last 5 years, Bausch & Lomb's Asset Writedowns and Impairment had its largest YoY gain of 8750.0% in 2022, and its largest YoY loss of 8750.0% in 2022.
  • Over the past 3 years, Bausch & Lomb's Asset Writedowns and Impairment (Quarter) stood at $1.0 million in 2021, then changed by 0.0% to $1.0 million in 2022, then surged by 400.0% to $5.0 million in 2024.
  • Its last three reported values are $5.0 million in Q2 2024, $1.0 million for Q3 2022, and $1.0 million during Q4 2021.